Kwality Pharmaceuticals Ltd
NSE:KPL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Kwality Pharmaceuticals Ltd (KPL) under the Base Case is 822.27 INR per share.
Compared with the current market price of 4 048.4 INR, the stock appears
Overvalued by 80% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Kwality Pharmaceuticals Does
Kwality Pharmaceuticals makes finished medicines. It turns active drug ingredients into products such as tablets, capsules, syrups, and injections, then sells them to hospitals, pharmacies, distributors, and other medicine buyers in India and overseas. The company earns money mainly by manufacturing and selling these drug products, sometimes under its own brands and sometimes for other companies.
- Headquarters
- India IN
- IPO date
- Jul 18, 2016
Continue KPL Research
Decided on Kwality Pharmaceuticals? Get an email when KPL reaches the price you’d buy at. Free with an account.
Other Kwality Pharmaceuticals listings
What is the Intrinsic Value of one KPL stock?
The intrinsic value for
Kwality Pharmaceuticals Ltd (KPL) under the Base Case is 822.27 INR.
Is KPL stock undervalued or overvalued?
Compared with the current market price of 4 048.4 INR, the stock appears Overvalued by 80% .